kabutan

CHUGAI PHARMA, Apr-Jun (2Q) Net Income Decreases by 13%

Thu Jul 24, 2025 4:00 pm JST Earnings

4519 CHUGAI PHARMACEUTICAL CO., LTD. 【IFRS】

Earnings Report

CHUGAI PHARMACEUTICAL CO., LTD. <4519> [TSE Prime] announced its financial results (based on IFRS) after the market closed on July 24th (16:00). The consolidated net income for the cumulative second quarter of the fiscal year ending December 2025 (January to June) increased 4.4% from the same period last year, reaching 194 billion yen.

In the most recent three-month period, from April to June (2Q), the consolidated net income decreased to 97.1 billion yen, a 13.1% decrease compared to the same period last year. The operating profit margin decreased from 50.1% in the same period last year to 47.1%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 579,657 210,910 213,656 156,693 95.3 48.1 Jul 27, 2023 IFRS
Jan - Jun, 2024 552,860 258,195 258,690 186,262 113.2 47.6 Jul 25, 2024 IFRS
Jan - Jun, 2025 578,463 273,342 271,830 194,389 118.1 ー Jul 24, 2025 IFRS
YoY +4.6% +5.9% +5.1% +4.4% +4.4%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － 125 Jan 30, 2025 IFRS
Jan - Jun, 2025 Results 578,463 273,342 271,830 194,389 118.1 125 Jul 24, 2025 IFRS
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 617,751 283,807 284,344 201,055 122.2 57 Jan 30, 2025 IFRS
Jul - Dec, 2025 Guidance 611,537 ー ー ー － 125 Jul 24, 2025 IFRS
YoY -1.0% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 1,111,367 439,174 443,821 325,472 197.8 80 Feb 1, 2024 IFRS
Dec, 2024 1,170,611 542,002 543,034 387,317 235.4 98 Jan 30, 2025 IFRS
Dec, 2025 Guidance 1,190,000 ー ー ー － 250 Jan 30, 2025 IFRS
YoY +1.7% － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 315,911 158,321 158,801 111,861 68.0 50.1 Jul 25, 2024 IFRS
Jul - Sep, 2024 315,678 160,407 158,837 109,496 66.6 50.8 Oct 25, 2024 IFRS
Oct - Dec, 2024 302,073 123,400 125,507 91,559 55.6 40.9 Jan 30, 2025 IFRS
Jan - Mar, 2025 288,459 136,651 135,829 97,234 59.1 47.4 Apr 24, 2025 IFRS
Apr - Jun, 2025 290,004 136,691 136,001 97,155 59.0 47.1 Jul 24, 2025 IFRS
YoY -8.2% -13.7% -14.4% -13.1% -13.2%

Related Articles